CORCEPT THERAPEUTICS INC — Director's Dealing 2021

Feb 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2021-02-11

Reporting Person: Robb Gary Charles (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-11	Common Stock	S	3400	$29.7791	Disposed	197738	Direct
2021-02-12	Common Stock	S	112100	$28.2239	Disposed	85638	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4564	Indirect
Common Stock	4564	Indirect
Common Stock	4564	Indirect

Footnotes

F1: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $29.7826 to $29.7783. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $28.00 to $28.515. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

F3: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.